CheckMate-032 Study: promising efficacy with nivolumab-based immunotherapy in pretreated esophagogastric cancer.
CheckMate-032 Study: promising efficacy with nivolumab-based immunotherapy in pretreated esophagogastric cancer.
J Thorac Dis. 2019 Mar;11(Suppl 3):S394-S395
Authors: Sun S, Kim JJ, Ko YH
PMID: 30997229 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research